Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects

NCT01425450 is registered in ClinicalTrials.gov with Trident Pharmaceuticals Inc as lead sponsor.

NCT NCT01425450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind Placebo-controlled Study to Assess the Safety of Four Single Ascending Doses of HF1020 in Healthy Male Subjects
Lead sponsor
Trident Pharmaceuticals Inc
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2011
Completion date
October 31, 2011
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer study